Adeno-associated Virus Based Vectors As Antivirals

  • K. K. WongJr.
  • S. Chatterjee
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 218)


Although great strides have been made in the treatment and prevention of human viral infections, antiviral drug therapy still remains problematic when compared to treatment of bacterial infections. The therapeutic toxicity/efficacy ratio of many antivirals is low, resulting in potential risks of regimen related toxicity. The number of effective antivirals is limited, and many important viral infections remain untreatable. In addition, currently used antivirals often suppress rather than cure infections, necessitating repeated, sometimes lifelong, therapy to prevent recurrences. Furthermore, the increasing use of antivirals has resulted in the selection or emergence of drug-resistant strains as has occurred following the widespread use of antibacterial (Field and Biron 1994). Finally, several medically important viruses, most notably human immunodeficiency virus (HIV), have been recalcitrant to either the development of curative chemotherapy or protective vaccines (Schnittman and Fauci 1994). Thus, novel approaches to the treatment or prevention of viral infections are constantly being sought.


Human Immunodeficiency Virus Long Terminal Repeat Antisense Transcript Cystic Fibrosis Transmembrane Regulator Hammerhead Ribozyme 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander IE, Russell DW, Miller AD (1994) DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J Virol 68: 8282–8287PubMedGoogle Scholar
  2. Allen ND, Cran DG, Barton SC, Hettle S, Reik R, Surani MAH (1988) Transgenes as probes for active chromosomal domains in mouse development. Nature 333: 852–855PubMedCrossRefGoogle Scholar
  3. Anderson WF (1992) Human Gene Therapy. Science 256: 808–813PubMedCrossRefGoogle Scholar
  4. Antoni BA, Rabson AB, Miller IL, Trempe JP, Chejanovsky N, Carter BJ (1991) Adeno-associated virus rep protein inhibits human immuno-deficiency virus type 1 production in human cells. J Virol 65: 396–404PubMedGoogle Scholar
  5. Arnheiter H, Skuntz S, Noteborn M, Chang S, Meier E (1990) Transgenic mice with intracellular immunity to influenza virus. Cell 62: 51–61PubMedCrossRefGoogle Scholar
  6. Bahner I, Zhou C, Yu XJ, Hao QL, Guatelli JC, Kohn DB (1993) Comparison of trans-dominant inhibitory mutant human immunodeficiency virus type 1 genes expressed by retroviral vectors in human T lymphocytes. J Virol 67: 3199–3207PubMedGoogle Scholar
  7. Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S (1994) Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 7: 254–260PubMedGoogle Scholar
  8. Baltimore D (1988) Intracellular immunization. Nature 335: 395–396PubMedCrossRefGoogle Scholar
  9. Bantel-Schaall U, zur Hausen H (1988) Adeno-associated viruses inhibit SV40 DNA amplification and replication of herpes simplex virus in SV40-transformed hamster cells. Virology 164: 64–74CrossRefGoogle Scholar
  10. Bass BL, Weintraub H (1988) An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55: 1089–1098PubMedCrossRefGoogle Scholar
  11. Bednarik DP, Mosca JD, Raj NBK, Pitha PM (1989) Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha-2 interferon. Proc Natl Acad Sci USA 86: 4958–4962PubMedCrossRefGoogle Scholar
  12. Berns KI, Bohenzky RA (1987) Adeno-associated viruses: an update. Adv Virus Res 32: 243–306PubMedCrossRefGoogle Scholar
  13. Berns KI, Pinkerton TC, Thomas GF, Hoggan MD (1975) Detection of adeno-associated virus (AAV)-spceifie nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68: 556–560PubMedCrossRefGoogle Scholar
  14. Bevec D, Volc-Platzer B, Zimmermann K, Dobrovnik M, Hauber J, Veres G, Bohnlein E (1994) Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes. Hum Gene Ther 5: 193–201PubMedCrossRefGoogle Scholar
  15. Bertrand EL, Rossi JJ (1994) Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1. EMBO J 13: 2904–2912PubMedGoogle Scholar
  16. Blaese RM (1993) Development of gene therapy for immunodeficiency: adenosine deaminase deficiency. Pediatr Res 33 [Suppl]: S49-S53PubMedCrossRefGoogle Scholar
  17. Bohnlein S, Pirker FP, Hofer L, Zimmermann K, Bachmayer H, Bohnlein E, Hauber J (1991) Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. J Virol 65: 81–88PubMedGoogle Scholar
  18. Brady HJ, Miles CG, Pennington DJ, Dzierzak EA (1994) Specific ablation of human immunodeficiency virus Tat-expressing cells by conditionally toxic retroviruses. Proc Natl Acad Sci USA 91: 365–369PubMedCrossRefGoogle Scholar
  19. Brenner MK, Rill DR, Holladay MS, Heslop HE, Moen RC, Buschle M, Krance RA, Santana VM, Anderson WF, Ihle JN (1993) Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet 342: 1134–1137PubMedCrossRefGoogle Scholar
  20. Bruton JK, Koeller JM (1994) Recombinant interleukin-2. Pharmacotherapy 14: 635–656PubMedGoogle Scholar
  21. Buchschacher GL, Freed EO, Panganiban AT (1992) Cells induced to express a human immunodeficiency virus type 1 envelope gene mutant inhibit the spread of wild-type virus. Hum Gene Ther 3: 391–397PubMedCrossRefGoogle Scholar
  22. Buonocore L, Rose JK (1990) Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum. Nature 345: 625–628PubMedCrossRefGoogle Scholar
  23. Buonocore L, Rose JK (1993) Blockade of human immunodeficiency virus type 1 production in CD4+ T cells by an intracellular CD4 expressed under control of the viral long terminal repeat. Proc Natl Acad Sci USA 90: 2695–2699PubMedCrossRefGoogle Scholar
  24. Carter RB, Abrams-Ogg AC, Dick JE, Kruth SA, Valli VE, Kamel-Reid S, Dube ID (1992) Autologous transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors. Blood 79: 356–364PubMedGoogle Scholar
  25. Castanotto D, Rossi JJ, Sarver N (1994) Antisense catalytic RNAs as therapeutic agents. Adv Pharm 25: 289–317CrossRefGoogle Scholar
  26. Casto BC, Armstrong JA, Atchinson RW, Hammon WMcD (1967) Studies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses. II. Inhibition of adenovirus plaques by AAV; its nature and specificity. Virology 33: 452–458PubMedCrossRefGoogle Scholar
  27. Cech TR, Bass BL (1986) Biological catalysis by RNA. Annu Rev Biochem 55: 599–629PubMedCrossRefGoogle Scholar
  28. Chang L-J, Stoltzfus CM (1987) Inhibition of Rous sarcoma virus replication antisense RNA. J Virol 61: 921–924PubMedGoogle Scholar
  29. Chatterjee S, Wong KK Jr (1993) Adeno-associated viral vectors for the delivery of antisense RNA. Methods (a companion to methods. Enzymol) 5: 51–59CrossRefGoogle Scholar
  30. Chatterjee S, Johnson PR, Wong KK Jr (1992a) Dual target inhibition of HIV-1 in vitro by means of an adeno-associated virus antisense vector. Science 258: 1485–1488PubMedCrossRefGoogle Scholar
  31. Chatterjee S, Wong KK, Podsakoff G, Zaia J, Forman S (1992b) Adeno-associated virus vectors for high efficiency gene transfer into primary hematopoietic cells. Blood 80: 167aGoogle Scholar
  32. Chatterjee S, Podsakoff G, Wong KK Jr (1994) Gene transfer into terminally differentiated primary human peripheral blood-derived mononuclear cells by adeno-associated virus. Blood 84: 360aGoogle Scholar
  33. Chatterjee S, Wong KK Jr, Lu D, Permana P, Podsakoff G. Novel approaches for efficient gene transfer into hematopoietic progenitor cells: the use of adeno-associated virus vectors. Bone Marrow Transplant (in press)Google Scholar
  34. Chatterjee S, Podsakoff G, Forman SJ, Wong KK Jr (1995) Adeno-associated virus-mediated gene transfer into CD34+ primary human hematopoietic progenitor cells is highly efficient and stable (submitted)Google Scholar
  35. Chen SY, Khouri Y, Bagley J, Marasco WA (1994) Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody. Proc Natl Acad Sci USA 91: 5932–5936PubMedCrossRefGoogle Scholar
  36. Chuah MKL, Vandendriessche T, Chang H-K, Ensoli B, Morgan RA (1994) Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR. Hum Gene Ther 5: 1467–1475PubMedCrossRefGoogle Scholar
  37. Curiel TJ, Cook DR, Wang Y, Hahn BH, Ghosh SK, Harrison GS (1993) Long-term inhibition of clinical and laboratory human immunodeficiency virus strains in human T-cell lines containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther 4: 741–747PubMedCrossRefGoogle Scholar
  38. Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, van Wezenbeek P, Melief C, Berns A (1984) Murine leukemia virus-induced T-cell lymphomagensis: integration of proviruses in a distinct chromosomal region. Cell 37: 141–150PubMedCrossRefGoogle Scholar
  39. Daar ES, Li XL, Moudgil T, Ho DD (1990) High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. Proc Natl Acad Sci USA 87: 6574–6578PubMedCrossRefGoogle Scholar
  40. Dalgleish AG, Beverley PCL, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312: 763–767PubMedCrossRefGoogle Scholar
  41. Donahue RE, Kessler SW, Bodine D, Monagh K, Dunbar C, Goodman S, Agricola B, Byrne E, Raffeid M, Meon R, Backer J, Zsebo KM, Nienhuis AW (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176: 1125–1135PubMedCrossRefGoogle Scholar
  42. Duan L, Bagasra O, Laughlin MA, Oakes JW, Pomerantz RJ (1994) Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-rev single chain antibody. Proc Natl Acad Sci USA 91: 5075–5077PubMedCrossRefGoogle Scholar
  43. Dunbar CE, Cottier-Fox M, O’Shaughnessy JA, Dören S, Carter C, Berenson R, Brown S, Moen RC, Greenblatt J, Stewart FM, Leitman SF, Wilson WH, Cowan K, Young NS, Nienhuis AW (1995) Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. Blood 85: 3048–3057PubMedGoogle Scholar
  44. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papilloma virus-16 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934–937PubMedCrossRefGoogle Scholar
  45. Eguchi Y, Itoh T, Tomizawa J (1991) Antisense RNA. Annu Rev Biochem 60: 631–652PubMedCrossRefGoogle Scholar
  46. Faraji-Shadan F, Stubbs JD, Bowman PD (1990) A putative approach for gene therapy against human immunodeficiency virus (HIV). Med Hypotheses 32: 81–84PubMedCrossRefGoogle Scholar
  47. Field AK, Biron KK (1994) The end of innocence revisited: resistance of herpesviruses to antiviral drugs. Clin Microbiol Rev 7: 1–13PubMedGoogle Scholar
  48. Flotte TR, Afione SA, Conrad C, McGrath SA, Solow R, Oka H, Zeitlin PL, Guggino WB, Carter BJ (1993) Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc Natl Acad Sci USA 90: 10613–10617PubMedCrossRefGoogle Scholar
  49. Flotte TR, Afione SA, Zeitlin PL (1994) Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am J Respir Cell Mol Biol 11: 517–521PubMedGoogle Scholar
  50. Flotte TR, Barraza-Ortiz X, Solow R, Afione SA, Carter BJ, Guggino WB (1995) An improved system for packaging recombinant adeno-associated virus vector capable of in vivo transduction. Gene Therapy 2: 29–37PubMedGoogle Scholar
  51. Friedman AD, Triezenberg SJ, McKnight SL (1988) Expression of a truncated viral transactivator selectively impedes lytic infection by its cognate virus. Nature 335: 452–454PubMedCrossRefGoogle Scholar
  52. Galpin JE, Casciato DA, Richards SB (1994) A phase I clinical trial to evaluate the safety and biological activity of HIV-IT (TAF) (HIV-1 III Benv-transduced, autologous fibroblasts) in asymptomatic HIV-1 infected subjects. Hum Gene Ther 5: 997–1017PubMedCrossRefGoogle Scholar
  53. Goodman S, Xiao X, Donahue RE, Moulton A, Miller J, Walsh C, Young NS, Samulski RJ, Nienhuis AW (1994) Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells. Blood 84: 1492–1500PubMedGoogle Scholar
  54. Green M, Ishino M, Loewenstein PM (1989) Mutational analysis of HIV-1 Tat minimal domain peptides: identification of trans-dominant mutants that suppress HIV-LTR-driven gene expression. Cell 58: 215–223PubMedCrossRefGoogle Scholar
  55. Green PJ, Pines O, Inouye M (1986) The role of antisense RNA in gene regulation. Annu Rev Biochem 55: 569–597PubMedCrossRefGoogle Scholar
  56. Gresser I (1986) Interferon-induced diseases. In: Notkins AL, Oldstone MBA (eds) Concepts in viral pathogenesis II. Springer, Berlin Heidelberg New York, pp 232–242Google Scholar
  57. Haibert CL, Alexander IE, Wolgamot GM, Miller AD (1995) Adeno-associated virus vectors transduce primary cells much less efficiently than immortalized cells. J Virol 69: 1473–1479Google Scholar
  58. Han L, Yun JS, Wagner TE (1991) Inhibition of Moloney murine leukemia virus-induced leukemia in transgenic mice expressing antisense RNA complementary to the retroviral packaging sequences. Proc Natl Acad Sci USA 88: 4313–4317PubMedCrossRefGoogle Scholar
  59. Harrison GS, Long CJ, Curiel TJ, Maxwell F, Maxwell IH (1992) Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene. Hum Gene Ther. 3: 461–469PubMedCrossRefGoogle Scholar
  60. Hartung S, Jaenisch R, Breindl M (1986) Retrovirus insertion inactivates mouse al(l) collagen gene by blocking initiation of transcription. Nature 320: 365–367PubMedCrossRefGoogle Scholar
  61. Haseloff J, Gerlach WL (1988) Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 334: 585–591PubMedCrossRefGoogle Scholar
  62. Hayward WS, Neel BG, Astrin SM (1981) Activation of a cellular oncogene by promoter insertion in ALV-induced lymphoid leukosis. Nature 290: 475–480PubMedCrossRefGoogle Scholar
  63. Helene C, Toulme J-J (1990) Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1049: 99–125PubMedGoogle Scholar
  64. Hermonat PL (1989) The adeno-associated virus rep 78 gene inhibits cellular transformation induced by bovine papillomavirus. Virology 172: 253–261PubMedCrossRefGoogle Scholar
  65. Hermonat PL (1991) Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res 51: 3373–3377PubMedGoogle Scholar
  66. Hermonat PL (1994) Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res 54: 2278–2281PubMedGoogle Scholar
  67. Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci USA 81: 6466–6470PubMedCrossRefGoogle Scholar
  68. Herskowitz I (1987) Functional inactivation of genes by dominant negative mutations. Nature 329: 219–222PubMedCrossRefGoogle Scholar
  69. Huibregtse JM, Scheffner 1994) Mechanisms of tumor suppressor protein inactivation by the human papillomavirus E6 and E7 oncoproteins. Semin Virol 5: 357–367CrossRefGoogle Scholar
  70. James W (1991) Towards gene-inhibition therapy: a review of progress and prospects in the field of antiviral antisense nucleic acids and ribozymes. Antiviral Chem Chemother 2: 191–214Google Scholar
  71. Joshi S, van Brunschot A, Asad S, van der Elst I, Read SE, Bernstein A (1991) Inhibition of human immunodeficiency virus type 1 multiplication by antisense and sense RNA expression. J Virol 65: 5524–5530PubMedGoogle Scholar
  72. Kaniewski WK, Thomas PE (1993) Field testing of virus resistant transgenic plants. Semin Virol 4: 389–396CrossRefGoogle Scholar
  73. Kantoff PW, Gillio AP, McKachlin JR, Bordignon C, Eglitis MA, Kernan NA, Moen RC, Kohn DB, Yu S-F, Karson E, Karlsson S, Zwiebel JA, Gilboa E, Blaese RM, Nienhuis A, O’Reilly RJ, Anderson WF (1987) Expression of human adenosine deaminase in nonhuman primates after retrovirusmediated gene transfer. J Exp Med 166: 219–234PubMedCrossRefGoogle Scholar
  74. Kaplitt MG, Leone P, Samulski RJ, Xiao X, Pfaff DW, O’Malley KL, During MJ (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet 8: 148–153PubMedCrossRefGoogle Scholar
  75. Kotin RM (1994) Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum Gene Ther 5: 793–801PubMedCrossRefGoogle Scholar
  76. Kotin RM, Siniscalco M, Samulski RJ, Zhu X, Hunter L, Laughlin CA, McLaughlin S, Muzyczka N, Rocchi M, Berns KI (1990) Site-specific integration by adeno-associated virus. Proc Natl Acad Sci USA 87: 2211–2215PubMedCrossRefGoogle Scholar
  77. Kung HJ, Boerkel C, Carter TH (1991) Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. In: Kung HJ, Vogt PK (eds) Retroviral insertional mutagenesis and oncogene activation. Springer, Berlin Heidelberg New York, pp 1–23 (Current topics in microbiology and immunology, vol 171)CrossRefGoogle Scholar
  78. LaFace D, Hermonat P, Wakeland E, Peck A (1988) Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology 162: 483–486PubMedCrossRefGoogle Scholar
  79. Lebkowski JS, McNally MM, Okarma TB, Lerch LB (1988) Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol Cell Biol 8: 3988–3996PubMedGoogle Scholar
  80. Lee TC, Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1992) Overexpression of RRE-derived sequences inhibits HIV-1 replication in CEM cells. New Biol 4: 66–74PubMedGoogle Scholar
  81. Liem SE, Ramezani A, Li X, Joshi S (1993) The development and testing of retroviral vectors expressing trans-dominant mutants of HIV-1 proteins to confer anti-HIV-1 resistance. Hum Gene Ther 4: 625–634PubMedCrossRefGoogle Scholar
  82. Lin X, Dashti A, Schinazi RF, Tang J (1993) Intracellular diversion of glycoprotein GP160 of human immunodeficiency virus to lysosomes as a strategy of AIDS gene therapy. FASEB J 7: 1070–1080PubMedGoogle Scholar
  83. Lisziewicz J, Sun D, Smythe J, Lusso P, Lori F, Louie A, Markham P, Rossi J, Reitz M, Gallo RC (1993) Inhibition of human immunodeficiency virus type 1 replication by regulated expression of a polymeric Tat activation response RNA decoy as a strategy for gene therapy in AIDS. Proc Natl Acad Sci USA 90: 8000–8004PubMedCrossRefGoogle Scholar
  84. Liu J, Woffendin C, Yang A, Nabel GJ (1994) Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther 1: 32–27PubMedGoogle Scholar
  85. Lu D, Chatterjee S, Brar D, Wong KK Jr (1994a) High efficiency in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16 mediated by ribozymes transcribed from an adeno-associated virus-based vector. Cancer Gene Ther 1: 267–277PubMedGoogle Scholar
  86. Lu D, Wong KK Jr, Podsakoff G, Chatterjee S (1994b) Stable and efficient adeno-associated virusmediated gene transfer into primitive human marrow-derived hematopoietic cells in long term culture. Blood 84: 360aGoogle Scholar
  87. Lusso P, Veronese F, Ensoli B, Franchini G, Jemma C, dePocco SE, Kalyanaraman VS, Gallo RC (1990) Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247: 848–852PubMedCrossRefGoogle Scholar
  88. Maciejewski JP, Weichold FF, Young NS, Cara A, Zella D, Reitz MS Jr, Gallo RC (1995) Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nature Med 1: 667–673PubMedCrossRefGoogle Scholar
  89. Malim MH, Freimuth WW, Liu J, Boyle TJ, Lyerly HK, Cullen BR, Nabel GJ (1992) Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med 176: 1197–1201PubMedCrossRefGoogle Scholar
  90. Marasco WA, Haseltine WA, Chen SY (1993) Design, intracellular expression, and activity of a human anti-human immunodeficiency virus typel gp120 single-chain antibody. Proc Natl Acad Sci USA 90: 7889–7893PubMedCrossRefGoogle Scholar
  91. Mayor HD (1993) Defective parvoviruses may be good for your health! Prog Med Virol 40: 193–205PubMedGoogle Scholar
  92. McLaughlin SK, Collis P, Hermonat PL, Muzyczka N (1988) Adeno-associated virus general transduction vectors: analysis of proviral structures. J Virol 62: 1963–1973PubMedGoogle Scholar
  93. Mendelson E, Grossman Z, Mileguir F, Rechavi G, Carter BJ (1992) Replication of adeno-associated virus type 2 in human lymphocytic cells and interaction with HIV-1. Virology 187: 453–463PubMedCrossRefGoogle Scholar
  94. Miller AD (1992a) Retroviral vectors. In: Muzyczka N (ed) Viral expression vectors. Springer, Berlin Heidelberg Neork, pp1–24 (Current topics in microbiology and immunology, vol 158)CrossRefGoogle Scholar
  95. Miller AD (1992b) Human gene therapy comes of age. Nature 357: 455–460PubMedCrossRefGoogle Scholar
  96. Miller DG, Adam MA, Miller AD (1990) Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 10: 4239–4242PubMedGoogle Scholar
  97. Miroshnichenko OI, Ponomareva TI, Tikchonenko TI (1989) Inhibition of adenovirus 5 replication in COS-1 cells by antisense RNAs against the viral E1a region. Gene 84: 83–89PubMedCrossRefGoogle Scholar
  98. Morgan RA, Looney DJ, Muenchau DD, Wong-Staal F, Gallo RC, Anderson WF (1990) Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS. AIDS Res Hum Retroviruses 6: 183–191PubMedCrossRefGoogle Scholar
  99. Mulligan RC (1993) The basic science of gene therapy. Science 260: 926–932PubMedCrossRefGoogle Scholar
  100. Muro-Cacho CA, Samulski RJ, Kaplan D (1992) Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J Immunother 11: 231–237PubMedCrossRefGoogle Scholar
  101. Muzyczka N (1992) Use of AAV as a general transduction vector for mammalian cells. Curr Top Micorb Immunol 158: 97–129CrossRefGoogle Scholar
  102. Nabel GJ, Fox BA, Post L, Thompson CB, Woffendin C (1994) A molecular genetic intervention for AIDS-effects of a transdominant negative form of Rev. Hum Gene Ther 5: 79–92PubMedCrossRefGoogle Scholar
  103. Nakagawa Y, Kakimi K, Ling W, Kubo Y, Higo K, Masuda T, Kuribayashi K, Iwashiro M, Komatz Y, Hirama T, Adachi A, Ishimoto A (1994) Inhibition of murine AIDS (MAIDS), development by the transplantation of bone marrow cells carrying the Fv-4 resistance gene to MAIDS virus-infected mice. J Virol 68: 1438–1441PubMedGoogle Scholar
  104. Natsoulis G, Seshaiah P, Federspiel MJ, Rein A, Hughes SH, Boeke JD (1995) Targeting of a nuclease to murine leukemia virus capsids inhibits viral multiplication. Proc Natl Acad Sci USA 92: 364–368PubMedCrossRefGoogle Scholar
  105. Oelze I, Rittner K, Sczakiel G (1994) Adeno-associated virus type 2 rep gene-mediated inhibition of basal gene expression of human immunodeficiency virus type 1 involves its negative regulatory functions. J Virol 68: 1229–1233PubMedGoogle Scholar
  106. Ojwang JO, Hampel A, Looney DJ, Wong-Staal F, Rappaport J (1992) Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme. Proc Natl Acad Sci USA 89: 10802–10806PubMedCrossRefGoogle Scholar
  107. Ostrove JM, Duckworth DH, Berns KI (1981) Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology 113: 521–533PubMedCrossRefGoogle Scholar
  108. Perriman R, Delves A, Gerlach WL (1992) Extended target-site specificity for a hammerhead ribozyme. Gene 113: 157–163PubMedCrossRefGoogle Scholar
  109. Podsakoff G, Wong KK Jr, Chatterjee S (1994a) Stable and efficient gene transfer into non-dividing cells by adeno-associated virus (AAV)-based vectors. J Virol 68: 5656–5666Google Scholar
  110. Podsakoff G, Shaughnessy EA, Lu D, Wong KK Jr, Chatterjee S (1994b) Long term in vivo reconstitution with murine marrow cells transduced with an adeno-associated virus vector. Blood 84: 256aGoogle Scholar
  111. Poeschla E, Wong-Staal F (1994) Antiviral and anticancer ribozymes. Curr Opin Oncol 6: 601–606PubMedCrossRefGoogle Scholar
  112. Ptashne M (1988) How eukaryotic transcriptional activators work. Nature 335: 683–689PubMedCrossRefGoogle Scholar
  113. Rhodes A, James W (1990) Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. J Gen Virol 71: 1965–1974PubMedCrossRefGoogle Scholar
  114. Richman DD (1993) HIV drug resistance. Annu Rev Pharmacol Toxicol 33: 149–164PubMedCrossRefGoogle Scholar
  115. Rittner K, Heilbronn R, Kleinschmidt JA, Sczakiel G (1992) Adeno-associated virus type 2-mediated inhibition of human immunodeficiency virus type 1 (HIV-1) replication: involvement of p78rep/p68 Rep and the HIV-1 long terminal repeat. J Gen Virol 73: 2977–2981PubMedCrossRefGoogle Scholar
  116. Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Byrn RA, Finer MH (1994) Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood 84: 2878–2889PubMedGoogle Scholar
  117. Roe TY, Reynolds TC, Yu G, Brown PO (1993) Integration of murine leukemia virus DNA depends on mitosis. EMBO J 12: 2099–2108PubMedGoogle Scholar
  118. Rommelaere J, Cornelis JJ (1991) Antineoplastic activity of parvoviruses. J Virol Methods 33: 233–251PubMedCrossRefGoogle Scholar
  119. Salter DW, Crittenden LB (1989) Artificial insertion of a dominant gene for resistance to avian leukosis virus into the germ line of the chicken. Theor Appl Genet 77: 457–461CrossRefGoogle Scholar
  120. Sarver N, Cantin EM, Chang PS, Zaia JA, Ladne PA, Stephens DA, Rossi JJ (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247: 1222–1225PubMedCrossRefGoogle Scholar
  121. Schlehofer JR (1994) The tumor suppressive properties of adeno-associated viruses. Mutat Res 305: 303–313PubMedCrossRefGoogle Scholar
  122. Schnittman SM, Fauci AS (1994) Human immunodeficiency virus and acquired immunodeficiency syndrome: an update. Adv Intern Med 39: 305–355PubMedGoogle Scholar
  123. Sczakiel G, Pawlita M (1991) Inhibition of human immunodeficiency virus type 1 replication in human T cells stably expressing antisense RNA. J Virol 65: 468–472PubMedGoogle Scholar
  124. Seif I, de Maeyer E, Riviere I, de Maeyer-Guignard J (1991) Stable antiviral expression in BALB/c 3T3 cells carrying a beta interferon sequence behind a major histocompatibility complex promoter fragment. J Virol 65: 664–671PubMedGoogle Scholar
  125. Shepard AA, Polentino P, Duca NA (1990) Trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol 64: 3916–3926PubMedGoogle Scholar
  126. Shillitoe EJ, Kamath P, Chen Z (1994) Papillomaviruses as targets for cancer gene therapy. Cancer Genher 1: 193–204Google Scholar
  127. Shimada T, Fujii H, Maier B, Hayashi S, Mitsuya H, Broder S, Nienhuis AW (1991) Trial of antisense RNA inhibition of HIV replication and gene expression. Antiviral Chem Chemother 2: 133–142Google Scholar
  128. Smythe JA, Sun D, Thomson M, Markham PD, Reitz MS Jr, Gallo RC, Lisziewicz J (1994) A Revinducible mutant gag gene stably trasferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection. Proc Natl Acad Sci USA 91: 3657–3661PubMedCrossRefGoogle Scholar
  129. Staeheli P (1990) Interferon-induced proteins and the antiviral state. Adv Virus Res 38: 147–200PubMedCrossRefGoogle Scholar
  130. Sullenger BA, Lee TC, Smith CA, Ungers GE, Gilboa E (1990a) Expression of chimeric NA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication. Mol Cell Biol 10: 6512–6523PubMedGoogle Scholar
  131. Sullenger BA, Gallardo HF, Ungers GE, Gilboa E (1990b) Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 63: 601–608PubMedCrossRefGoogle Scholar
  132. Tratschin JD, West MH, Sandbank T, Carter BJ (1984) A human parvovirus, adeno-associated virus, as a eucaryotic vector: transient expression and encapsidation of the procaryotic gene for chloramphenicol acetyltransferase. Mol Cell Biol 4: 2072–2081PubMedGoogle Scholar
  133. Trono D, Feinberg MB, Baltimore D (1989) HIV-1 gag mutants can dominantly interfere with the replication of the wild-type virus. Cell 59: 113–120PubMedCrossRefGoogle Scholar
  134. Vaishnav YN, Wong-Staal F (1991) The biochemistry of AIDS. Annu Rev Biochem 60: 577–630PubMedCrossRefGoogle Scholar
  135. Van der Krol AR, Mol JNM, Stuitje AR (1988) Modulation of eukaryotic gene expression by complementary RNA or DNA sequences. Biotechniques 6: 958–976PubMedGoogle Scholar
  136. Vieillard V, Lauret E, Rousseau V, De Maeyer E (1994) Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc Natl Acad Sci USA 91: 2689–2693PubMedCrossRefGoogle Scholar
  137. von Ruden T, Gilboa E (1989) Inhibition of human T-cell leukemia virus type 1 replication in primary human T cells that express antisense RNA. J Virol 63: 677–682Google Scholar
  138. Wagner EGH, Simons RW (1994) Antisense RNA control in bacteria, phages, and plasmids. Annu Rev Microbiol 48: 713–742PubMedCrossRefGoogle Scholar
  139. Walsh CE, Nienhuis AW, Samulski RJ, Brown MG, Miller JL, Young NS, Liu JM (1994a) Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 94: 1440–1448PubMedCrossRefGoogle Scholar
  140. Walsh CE, Liu IM, Wang S, Xiao X, Hashmi NJ, Zwerdling T, Agarwal R (1994b) In vivo gene transfer with a novel adeno-associated virus vector to human hematopoietic cells engrafted in SCID-hu mice. Blood 84: 256aGoogle Scholar
  141. Warner JF, Anderson CG, Laube L, Jolly DJ, Townsend K, Chada S, St Louis D (1991) HIV-specific CTL and antibody responses in mice using retroviral vector-transduced cells. Aids Res Hum Retroviruses 7: 645–655PubMedCrossRefGoogle Scholar
  142. Watson RJ, Clemens JB (1980) A herpes simplex virus type 1 function continuously required for early and late virus RNA synthesis. Nature 285: 329–330PubMedCrossRefGoogle Scholar
  143. Weerasinghe M, Liem SE, Asad S, Read SE, Joshi S (1991) Resistance to human immunodeficiency virus type 1 (HIV-1) infection in human CD4+ lymphocyte-derived cell lines conferred by using retroviral vectors expressing an HIV-1 RNA-specific ribozyme. J Virol 65: 5531–5534PubMedGoogle Scholar
  144. Weintraub H, Izant JG, Harland RM (1985) Anti-sense RNA as a molecular tool for genetic analysis. Trends Genet 2: 22–25CrossRefGoogle Scholar
  145. Werge TM, Biocca S, Cattaneo A (1990) Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein. FEBS Lett 274: 193–198PubMedCrossRefGoogle Scholar
  146. Werness BA, Levine A, Howley PM (1990) Association of human papilloma virus type 16 and 18 E6 proteins with p53. Science. 248: 76–79PubMedCrossRefGoogle Scholar
  147. Woffendin C, Yang ZY, Udaykumar, Xu L, Yang NS, Sheehy MJ, Nabel GJ (1994) Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells. Proc Natl Acad Sci USA 91: 11581–11585PubMedCrossRefGoogle Scholar
  148. Wong KK Jr, Chatterjee S (1992) Controlling herpes simplex virus (HSV) infections: intracellular immunization, the way of the future? Curr Top Micro Immunol 179: 159–174CrossRefGoogle Scholar
  149. Wong KK Jr, Chatterjee S (1992) In: Rouse BT (ed) Herpes Simplex virus. Springer, Berlin Heidelberg New York, pp 159–174 (Current topics in microbiology and immunology, vol 179)CrossRefGoogle Scholar
  150. Wong KK Jr, Rose JA, Chatterjee S (1991) Restriction of HSV-1 production in cell lines transduced with an antisense viral vector targeting the ICP4 gene. (Vaccine, vol 91) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, pp 183–189Google Scholar
  151. Yamada O, Yu M, Yee J-K, Kraus G, Looney D, Wong-Staal F (1994) Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther 1: 38–45PubMedGoogle Scholar
  152. Yang Q, Chen F, Trempe JP (1994) Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins. J Virol 68: 4847–4856PubMedGoogle Scholar
  153. Yu M, Ojwang J, Yamada O, Hampel A, Rapapport J, Looney D, Wong-Staal F (1993) A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90: 6340–6344PubMedCrossRefGoogle Scholar
  154. Yu M, Poeschla E, Wong-Staal F (1994) Progress towards gene therapy for HIV infection. Gene Ther 1: 13–26PubMedGoogle Scholar
  155. Zaia JA, Chatterjee S, Wong KK, Elkins D, Taylor NR, Rossi JJ (1992) Status of ribozyme and antisense-based developmental approaches for anti-HIV-1 therapy. Ann N Y Acad Sci 660: 95–105PubMedCrossRefGoogle Scholar
  156. Zhou C, Bahner IC, Larson GP, Zaia JA, Rossi JJ, Kohn DB (1994) Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-faiand rev hammerhead ribozymes. Gene 149: 33–39PubMedCrossRefGoogle Scholar
  157. Zhou SZ, Cooper S, Kang LY, Ruggieri L, Heimfeld S, Srivastava A, Broxmeyer HE (1994) Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood. J Exp Med 179: 1867–1875PubMedCrossRefGoogle Scholar
  158. zur Hausen H, de Villiers EM (1994) Human papillomaviruses. Annu Rev Microbiol 48: 427–447PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • K. K. WongJr.
    • 1
  • S. Chatterjee
    • 2
  1. 1.Departments of Hematology and Bone Marrow Transplantation, Infectious DiseasesDuarteUSA
  2. 2.Division of Pediatrics, Beckman Research InstituteCity of Hope National Medical CenterDuarteUSA

Personalised recommendations